Abstract:Multidrug resistance protein MRP1 mediates the ATP-dependent efflux of many chemotherapeutic agents and organic anions. MRP1 has two nucleotide binding sites (NBSs) and three membrane spanning domains (MSDs) containing 17 transmembrane helices linked by extracellular and cytoplasmic loops (CL). Homology models suggest that CL7 (amino acids 1141-
“…Site-directed mutagenesis and vesicular transport assays have been used extensively to identify particular domains or amino acids involved in the substrate selectivity and transport mechanism of MRP1 (Ren et al, 2002;Conseil et al, 2006Conseil et al, , 2009Deeley and Cole, 2006;Chang 2007). Evidence gathered to date supports a model in which each substrate of MRP1 establishes its own distinct and often mutually exclusive interactions with amino acids in at least one substrate binding pocket of the transporter.…”
Section: Discussionmentioning
confidence: 96%
“…In this way, a number of amino acids important for the stable plasma membrane expression of MRP1, or for its overall activity, have been identified (Haimeur et al, 2002Ren et al, 2002;Koike et al, 2004;Situ et al, 2004;Conseil et al, 2006Conseil et al, , 2009Deeley and Cole, 2006;Chang 2007). Amino acids important for the substrate specificity of MRP1 have also been identified, two of which are Lys 332 , located in TM6 in the second MSD, and Trp 1246 , located in TM17 in the third MSD (Fig.…”
ABSTRACT:Multidrug resistance protein 1 (MRP1) confers drug resistance and also mediates cellular efflux of many organic anions. MRP1 also transports glutathione (GSH); furthermore, this tripeptide stimulates transport of several substrates, including estrone 3-sulfate.
“…Site-directed mutagenesis and vesicular transport assays have been used extensively to identify particular domains or amino acids involved in the substrate selectivity and transport mechanism of MRP1 (Ren et al, 2002;Conseil et al, 2006Conseil et al, , 2009Deeley and Cole, 2006;Chang 2007). Evidence gathered to date supports a model in which each substrate of MRP1 establishes its own distinct and often mutually exclusive interactions with amino acids in at least one substrate binding pocket of the transporter.…”
Section: Discussionmentioning
confidence: 96%
“…In this way, a number of amino acids important for the stable plasma membrane expression of MRP1, or for its overall activity, have been identified (Haimeur et al, 2002Ren et al, 2002;Koike et al, 2004;Situ et al, 2004;Conseil et al, 2006Conseil et al, , 2009Deeley and Cole, 2006;Chang 2007). Amino acids important for the substrate specificity of MRP1 have also been identified, two of which are Lys 332 , located in TM6 in the second MSD, and Trp 1246 , located in TM17 in the third MSD (Fig.…”
ABSTRACT:Multidrug resistance protein 1 (MRP1) confers drug resistance and also mediates cellular efflux of many organic anions. MRP1 also transports glutathione (GSH); furthermore, this tripeptide stimulates transport of several substrates, including estrone 3-sulfate.
“…For example, Ala substitution of several charged amino acids in MSD1-CL5 and MSD2-CL7 causes misfolding of MRP1 resulting in reduced levels of the transporter at the plasma membrane (55)(56)(57)(58). Although both CL5 and CL7 are important, MSD1-CL5 and its bonding interactions with NBD2 appear to play a more pivotal role in the proper folding and membrane trafficking and function of MRP1 than do the domain-domain interactions involving MSD2-CL7 (56).…”
Section: Structural Determinants Of Solute Transport By Mrp1mentioning
The multidrug resistance protein 1 (MRP1) encoded by ABCC1 was originally discovered as a cause of multidrug resistance in tumor cells. However, it is now clear that MRP1 serves a broader role than simply mediating the ATP-dependent efflux of drugs from cells. The antioxidant GSH and the pro-inflammatory cysteinyl leukotriene C 4 have been identified as key physiological organic anions effluxed by MRP1, and an ever growing body of evidence indicates that additional lipid-derived mediators are also substrates of this transporter. As such, MRP1 is a multitasking transporter that likely influences the etiology and progression of a host of human diseases.
“…1A). Thus, mutation of the adjacent Tyr residues at positions 1189 and 1190 decreases MRP1 transport activity, especially with respect to the transport of the tripeptide antioxidant glutathione (21 (22,23). Homology models of the nucleotide-bound core structure of human MRP1 predict that a stretch of amino acids parallel to the membrane at the bottom of CL7 of MSD2 is in close proximity to the first NBD (NBD1), whereas the analogous region in CL5 of MSD1 is in contact with the second NBD (NBD2) (Fig.…”
, and Gly 511 had no effect on MRP1 levels. Except for K503A, however, transport by these mutants was reduced by 50 to 75%, an effect largely attributable to reduced substrate binding and affinity. Studies with 32 P-labeled azido-ATP also indicated that whereas ATP binding by the G511I mutant was unchanged, vanadate-induced trapping of azido-ADP was reduced, indicating changes in the catalytic activity of MRP1. Together, these data demonstrate the multiple roles for CL5 in the membrane expression and function of MRP1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.